Stem cell transplantation for rheumatic autoimmune diseases

Arthritis Research and Therapy

Volumn 10, Issue 5, 2008, Pages

  Hügle, Thomas ^a   Van Laar, Jacob M ^b  

^a UNIVERSITY OF BASEL   (Switzerland)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALEMTUZUMAB; ANTICOAGULANT AGENT; ANTINUCLEAR ANTIBODY; BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DISEASE MODIFYING ANTIRHEUMATIC DRUG; FLUDARABINE; GAMMA INTERFERON; HLA B27 ANTIGEN; INTERLEUKIN 10; MESSENGER RNA; METHOTREXATE; THYMOCYTE ANTIBODY; TRANSCRIPTION FACTOR GATA 3; TRANSCRIPTION FACTOR T BET;

ACUTE GRAFT VERSUS HOST DISEASE; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ANTIPHOSPHOLIPID SYNDROME; APLASTIC ANEMIA; AUTOIMMUNE DISEASE; AUTOIMMUNE THROMBOCYTOPENIA; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; B LYMPHOCYTE; BEHCET DISEASE; BLEEDING; CHRONIC GRAFT VERSUS HOST DISEASE; CLINICAL TRIAL; CYTOMEGALOVIRUS INFECTION; DENDRITIC CELL; DIABETES MELLITUS; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; JUVENILE RHEUMATOID ARTHRITIS; LUPUS LIKE SYNDROME; MESENCHYMAL STEM CELL TRANSPLANTATION; MONOCYTE; MORBIDITY; MORTALITY; MULTIPLE SCLEROSIS; MYELOABLATIVE CONDITIONING; NATURAL KILLER CELL; NONHUMAN; NONMYELOABLATIVE STEM CELL TRANSPLANTATION; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; QUALITY OF LIFE; REDUCED INTENSITY CONDITIONING; REGULATORY T LYMPHOCYTE; REVIEW; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; SEPSIS; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; T LYMPHOCYTE; THERAPY EFFECT; TREATMENT OUTCOME; TREATMENT RESPONSE; WEGENER GRANULOMATOSIS; WHOLE BODY RADIATION; ANIMAL; METHODOLOGY;

ANIMALS; AUTOIMMUNE DISEASES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; RHEUMATIC DISEASES;

EID: 54149083949     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar2486     Document Type: Review

References (65)

1. Jayne D Passweg J Marmont A Farge D Zhao X Arnold R Hiepe F Lisukov I Musso M Ou-Yang J Marsh J Wulffraat N Besalduch J Bingham SJ Emery P Brune M Fassas A Faulkner L Ferster A Fiehn C Fouillard L Geromin A Greinix H Rabusin M Saccardi R Schneider P Zintl F Gratwohl A Tyndall A European Group for Blood and Marrow Transplantation et al.: Autologous stem cell transplantation for systemic lupus erythematosus Lupus 2004, 13:168-176. 10.1191/0961203304lu525oa 15119545
2. Saccardi R Kozak T Bocelli-Tyndall C Fassas A Kazis A Havrdova E Carreras E Saiz A Löwenberg B te Boekhorst PA Gualandio F Openshaw H Longo G Pagliai F Massacesi L Deconink E Ouyang J Nagore FJ Besalduch J Lisukov IA Bonini A Merelli E Slavino S Gratwohl A Passweg J Tyndall A Steck AJ Andolina M Capobianco M Martin JL et al.: Autologous stem cell transplantation for progressive multiple sclerosis: Update of the European Group for Blood and Marrow Transplantation autoimmune diseases working party database Mult Scler 2006, 12:814-823. 10.1177/ 1352458506071301 17263012
3. Farge D Passweg J van Laar JM Marjanovic Z Besenthal C Finke J Peter HH Breedveld FC Fibbe WE Black C Denton C Koetter I Locatelli F Martini A Schattenberg AV Hoogen van den F Putte van de L Lanza F Arnold R Bacon PA Bingham S Ciceri F Didier B Diez-Martin JL Emery P Feremans W Hertenstein B Hiepe F Luosujärvi R Leon Lara A et al.: Autologous stem cell transplantation in the treatment of systemic sclerosis: Report from the EBMT/EULAR Registry Ann Rheum Dis 2004, 63:974-981. 1755096 15249325 10.1136/ard.2003.011205
4. Tyndall A Saccardi R Haematopoietic stem cell transplantation in the treatment of severe autoimmune disease: Results from phase I/II studies, prospective randomized trials and future directions Clin Exp Immunol 2005, 141:1-9. 1809422 15958063 10.1111/j.1365-2249.2005.02806.x
5. Nelson JL Torrez R Louie FM Choe OS Storb R Sullivan KM Pre-existing autoimmune disease in patients with long-term survival after allogeneic bone marrow transplantation J Rheumatol 1997, 48:23-29. 9150114
6. van Bekkum DW Stem cell transplantation in experimental models of autoimmune disease J Clin Immunol 2000, 20:10-16. 10.1023/ A:1006682225181 10798602
7. Morton JI Siegel BV Transplantation of Autoimmune Potential. I. Development of Antinuclear Antibodies in H-2 Histocompatible Recipients of Bone Marrow from New Zealand Black Mice Proc Natl Acad Sci USA 1974, 71:2162-2165. 388410 4601580 10.1073/pnas.71.6.2162
8. Ikehara S Kawamura M Takao F Inaba M Yasumizu R Than S Hisha H Sugiura K Koide Y Yoshida TO Ida T Imura H Good RA Organ-specific and systemic autoimmune diseases originate from defects in hematopoietic stem cells Proc Natl Acad Sci USA 1990, 87:8341-8344. 54951 2236044 10.1073/ pnas.87.21.8341
9. van Laar JM Immune ablation and stem-cell therapy in autoimmune disease. Immunological reconstitution after high-dose immunosuppression and haematopoietic stem-cell transplantation Arthritis Res 2000, 2:270-275. 130008 11094440 10.1186/ar101
10. van Gelder M van Bekkum DW Effective treatment of relapsing experimental autoimmune encephalomyelitis with pseudoautologous bone marrow transplantation Bone Marrow Transplant 1996, 18:1029-1034. 8971369
11. Van Wijmeersch B Sprangers B Rutgeerts O Lenaerts C Landuyt W Waer M Billiau AD Dubois B Allogeneic bone marrow transplantation in models of experimental autoimmune encephalomyelitis: Evidence for a graft-versus-autoimmunity effect Biol Blood Marrow Transplant 2007, 13:627-637. 10.1016/j.bbmt.2007.03.001 17531772
12. Smith-Berdan S Gille D Weissman IL Christensen JL Reversal of autoimmune disease in lupusprone New Zealand black/New Zealand white mice by nonmyeloablative transplantation of purified allogeneic hematopoietic stem cells Blood 2007, 15:110. 17435112
13. Burt RK Padilla J Begolka WS Canto MC Miller SD Effect of disease stage on clinical outcome after syngeneic bone marrow transplantation for relapsing experimental autoimmune encephalomyelitis Blood 1998, 91:2609-2616. 9516163
14. Herrmann MM Gaertner S Stadelmann C Brandt van den J Böscke R Budach W Reichardt HM Weissert R Tolerance induction by bone marrow transplantation in a multiple sclerosis model Blood 2005, 106:1875-1883. 10.1182/blood-2004-12-4607 15899918
15. Flierman R Witteveen HJ Voort van der EI Huizinga TW de Vries RR Fibbe WE Toes RE van Laar JM Control of systemic B cell-mediated autoimmune disease by nonmyeloablative conditioning and major histocompatibility complex-mismatched allogeneic bone marrow transplantation Blood 2005, 105:2991-2994. 10.1182/blood-2004-09-3715 15604221
16. Cho SG Min SY Park MJ Lee KW Cho YG Cho ML Chang HS Park SH Lee JW Min WS Kim CC Kim HY Immunoregulatory effects of allogeneic mixed chimerism induced by non-myeloablative bone marrow transplantation on chronic inflammatory arthritis and autoimmunity in interleukin-1 receptor antagonist-deficient mice Arthritis Rheum 2006, 54:1878-1887. 10.1002/ art.21888 16736524
17. Wekerle T Kurtz J Ito H Ronquillo JV Dong V Zhao G Shaffer J Sayegh MH Sykes M Allogeneic bone marrow transplantation with co-stimulatory blockade induces macrochimerism and tolerance without cytoreductive host treatment Nat Med 2000, 6:464-469. 10.1038/74731 10742157
18. Czechowicz A Kraft D Weissman IL Bhattacharya D Efficient transplantation via antibody-based clearance of hematopoietic stem cell niches Science 2007, 318:1296-1299. 2527021 18033883 10.1126/ science.1149726
19. Ogawa M Matsuzaki Y Nishikawa S Hayashi S Kunisada T Sudo T Kina T Nakauchi H Nishikawa S Expression and function of c-kit in hemopoietic progenitor cells J Exp Med 1991, 174:63-71. 2118893 1711568 10.1084/ jem.174.1.63
20. Breban M Hammer RE Richardson JA Taurog JD Transfer of the inflammatory disease of HLA-B27 transgenic rats by bone marrow engraftment J Exp Med 1993, 178:1607-1616. 2191228 8228809 10.1084/jem.178.5.1607
21. Nash RA McSweeney PA Crofford LJ Abidi M Chen CS Godwin JD Gooley TA Holmberg L Henstorf G LeMaistre CF Mayes MD McDonagh KT McLaughlin B Molitor JA Nelson JL Shulman H Storb R Viganego F Wener MH Seibold JR Sullivan KM Furst DE High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for severe systemic sclerosis: long-term follow-up of the US multicenter pilot study Blood 2007, 110:1388-1396. 1939909 17452515 10.1182/blood-2007-02-072389
22. Gratwohl A Passweg J Bocelli-Tyndall C Fassas A van Laar JM Farge D Andolina M Arnold R Carreras E Finke J Kötter I Kozak T Lisukov I Löwenberg B Marmont A Moore J Saccardi R Snowden JA Hoogen van den F Wulffraat NM Zhao XW Tyndall A Autoimmune Diseases Working Party of the European Group for Blood and Marrow Transplantation (EBMT) Autologous hematopoietic stem cell transplantation for autoimmune diseases Bone Marrow Transplant 2005, 35:869-879. 10.1038/sj.bmt.1704892 15765114
23. Burt RK Loh Y Pearce W Beohar N Barr WG Craig R Wen Y Rapp JA Kessler J Clinical applications of blood-derived and marrow-derived stem cells for nonmalignant diseases JAMA 2008, 299:925-936. 10.1001/jama.299.8.925 18314435
24. Burt RK Traynor A Statkute L Barr WG Rosa R Schroeder J Verda L Krosnjar N Quigley K Yaung K Villa Bs M Takahashi M Jovanovic B Oyama Y Nonmyeloablative hematopoietic stem cell transplantation for systemic lupus erythematosus JAMA 2006, 295:527-535. 10.1001/jama.295.5.527 16449618
25. Oyama Y Barr WG Statkute L Corbridge T Gonda EA Jovanovic B Testori A Burt RK Autologous non-myeloablative hematopoietic stem cell transplantation in patients with systemic sclerosis Bone Marrow Transplant 2007, 40:549-555. 10.1038/sj.bmt.1705782 17646844
26. Vonk MC Marjanovic Z Hoogen van den FH Zohar S Schattenberg AV Fibbe WE Larghero J Gluckman E Preijers FW van Dijk AP Bax JJ Roblot P van Riel PL van Laar JM Farge D Long-term follow-up results after autologous haematopoietic stem cell transplantation for severe systemic sclerosis Ann Rheum Dis 2008, 67:98-104. 10.1136/ard.2007.071464 17526554
27. Statkute L Traynor A Oyama Y Yaung K Verda L Krosnjar N Burt RK Antiphospholipid syndrome in patients with systemic lupus erythematosus treated by autologous hematopoietic stem cell transplantation Blood 2005, 106:2700-2709. 10.1182/blood-2005-01-0330 15870182
28. Mandelbrot DA Santos PW Burt RK Oyama Y Block GA Ahya SN Rosa RM Traynor AE Resolution of SLE-related soft-tissue calcification following haematopoietic stem celltransplantation Nephrol Dial Transplant 2008, 23:2679-2684. 10.1093/ndt/gfn036 18326564
29. Aschwanden M Daikeler T Jaeger KA Thalhammer C Gratwohl A Matucci-Cerinic M Tyndall A Rapid improvement of nailfold capillaroscopy after intense immunosuppression for systemic sclerosis and mixed connective tissue disease Ann Rheum Dis 2008, 67:1057-1059. 10.1136/ ard.2007.082008 18556454
30. Miniati I Guiducci S Conforti ML Rogai V Fiori G Cinelli M Saccardi R Guidi S Bosi A Tyndall A Matucci Cerinic M Autologous stem cell transplantation improves microcirculation in systemic sclerosis Ann Rheum Dis 2008, May 26.
31. Fleming JN Nash RA McLeod DO Fiorentino DF Shulman HM Connolly MK Molitor JA Henstorf G Lafyatis R Pritchard DK Adams LD Furst DE Schwartz SM Capillary regeneration in scleroderma: Stem cell therapy reverses phenotype? PLoS ONE 2008, 16:e1452. 18197262 2175530 10.1371/ journal.pone.0001452
32. Snowden JA Passweg J Moore JJ Milliken S Cannell P Van Laar J Verburg R Szer J Taylor K Joske D Rule S Bingham SJ Emery P Burt RK Lowenthal RM Durez P McKendry RJ Pavletic SZ Espigado I Jantunen E Kashyap A Rabusin M Brooks P Bredeson C Tyndall A Autologous hemopoietic stem cell transplantation in severe rheumatoid arthritis: A report from the EBMT and ABMTR J Rheumatol 2004, 31:482-488. 14994391
33. Verburg RJ Kruize AA Hoogen van den FH Fibbe WE Petersen EJ Preijers F Sont JK Barge RM Bijlsma JW Putte van de LB Breedveld FC van Laar JM High-dose chemotherapy and autologous hematopoietic stem cell transplantation in patients with rheumatoid arthritis: Results of an open study to assess feasibility, safety, and efficacy Arthritis Rheum 2001, 44:754-760. 10.1002/ 1529-0131(200104)44:4<754::AID-ANR131>3.0.CO;2-N 11315914
34. Brinkman DM de Kleer IM ten Cate R van Rossum MA Bekkering WP Fasth A van Tol MJ Kuis W Wulffraat NM Vossen JM Autologous stem cell transplantation in children with severe progressive systemic or polyarticular juvenile idiopathic arthritis: Long-term follow-up of a prospective clinical trial Arthritis Rheum 2007, 56:2410-2421. 10.1002/ art.22656 17599770
35. Statkute L Oyama Y Barr WG Sufit R Ho S Verda L Loh Y Yaung K Quigley K Burt RK Autologous non-myeloablative hematopoietic stem cell transplantation for refractory systemic vasculitis Ann Rheum Dis 2008, 67:991-997. 10.1136/ard.2007.070227 17947303
36. Daikeler T Kötter I Bocelli Tyndall C Apperley J Attarbaschi A Guardiola P Gratwohl A Jantunen E Marmont A Porretto F Musso M Maurer B Rinaldi N Saccardi R Tyndall A EBMT Autoimmune Diseases Working Party Haematopoietic stem cell transplantation for vasculitis including Behcet's disease and polychondritis: A retrospective analysis of patients recorded in the European Bone Marrow Transplantation and European League Against Rheumatism databases and a review of the literature Ann Rheum Dis 2007, 66:202-207. 10.1136/ard.2006.056630 16950809
37. Petri M Jones RJ Brodsky RA High-dose cyclophosphamide without stem cell transplantation in systemic lupus erythematosus Arthritis Rheum 2003, 48:166-173. 10.1002/art.10752 12528116
38. Tehlirian CV Hummers LK White B Brodsky RA Wigley FM High-dose cyclophosphamide without stem cell rescue in scleroderma Ann Rheum Dis 2008, 67:775-781. 10.1136/ard.2007.077446 17974598
39. Brodsky RA Sensenbrenner LL Jones RJ Complete remission in severe aplastic anemia after high-dose cyclophosphamide without bone marrow transplantation Blood 1996, 87:491-494. 8555470
40. Hinterberger W Hinterberger-Fischer M Marmont A Clinically demonstrable anti-autoimmunity mediated by allogeneic immune cells favorably affects outcome after stem cell transplantation in human autoimmune diseases Bone Marrow Transplant 2002, 30:753-759. 10.1038/sj.bmt.1703686 12439698
41. Nash RA McSweeney PA Nelson JL Wener M Georges GE Langston AA Shulman H Sullivan KM Lee J Henstorf G Storb R Furst DE Allogeneic marrow transplantation in patients with severe systemic sclerosis: Resolution of dermal fibrosis Arthritis Rheum 2006, 54:1982-1986. 10.1002/art.21908 16732546
42. Khorshid O Hosing C Bibawi S Ueno N Reveille J Mayes MD Champlin RE Nonmyeloablative stem cell transplant in a patient with advanced systemic sclerosis and systemic lupus erythematosus J Rheumatol 2004, 31:2513-2516. 15570660
43. Loh Y Oyama Y Statkute L Verda L Quigley K Yaung K Barr W Jovanovic B Burt RK Non-myeloablative allogeneic hematopoietic stem cell transplantation for severe systemic sclerosis: Graft-versus-autoimmunity without graft-versus-host disease? Bone Marrow Transplant 2007, 39:435-437. 10.1038/sj.bmt.1705611 17310133
44. Burt RK Oyama Y Verda L Quigley K Brush M Yaung K Statkute L Traynor A Barr WG Induction of remission of severe and refractory rheumatoid arthritis by allogeneic mixed chimerism Arthritis Rheum 2004, 50:2466-2470. 10.1002/art.20451 15334459
45. Snowden JA Kearney P Kearney A Cooley HM Grigg A Jacobs P Bergman J Brooks PM Biggs JC Long-term outcome of autoimmune disease following allogeneic bone marrow transplantation Arthritis Rheum 1998, 41:453-459. 10.1002/1529-0131(199803)41:3<453::AID-ART11>3.0.CO;2-# 9506573
46. Marmont AM Gualandi F Piaggio G Podestà M Teresa van Lint M Bacigalupo A Nobili F Allogeneic bone marrow transplantation (BMT) for refractory Behçet's disease with severe CNS involvement Bone Marrow Transplant 2006, 37:1061-1063. 10.1038/sj.bmt.1705372 16633360
47. Hoffmann P Edinger M CD4+CD25+ regulatory T cells and graft-versus-host disease Semin Hematol 2006, 43:62-69. 10.1053/j.seminhematol.2005.09.006 16412790
48. Le Blanc K Frassoni F Ball L Locatelli F Roelofs H Lewis I Lanino E Sundberg B Bernardo ME Remberger M Dini G Egeler RM Bacigalupo A Fibbe W Ringdén O Developmental Committee of the European Group for Blood and Marrow Transplantation Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: A phase II study Lancet 2008, 10:1579-1586. 18468541 10.1016/S0140-6736(08)60690-X
49. Siegal D Xu W Sutherland R Kamel-Reid S Kuruvilla J Lipton JH Minden M Messner H Gupta V Graft-versus-host disease following marrow transplantation for aplastic anemia: Different impact of two GVHD prevention strategies Bone Marrow Transplant 2008, 42:51-56. 10.1038/ bmt.2008.88 18372907
50. Burnet FM A modification of Jerne's theory of antibody production using the concept of clonal selection CA Cancer J 1976, 26:119-121. 816431 10.3322/canjclin.26.2.119
51. + regulatory T cells Blood 2008, 111:5233-5241. 10.1182/blood-2007-12-128488 18256318
52. de Kleer I Vastert B Klein M Teklenburg G Arkesteijn G Yung GP Albani S Kuis W Wulffraat N Prakken B Autologous stem cell transplantation for autoimmunity induces immunologic self-tolerance by reprogramming autoreactive T cells and restoring the CD4+CD25+ immune regulatory network Blood 2006, 107:1696-1702. 10.1182/blood-2005-07-2800 16263787
53. Muraro PA Douek DC Packer A Chung K Guenaga FJ Cassiani-Ingoni R Campbell C Memon S Nagle JW Hakim FT Gress RE McFarland HF Burt RK Martin R Thymic output generates a new and diverse TCR repertoire after autologous stem cell transplantation in multiple sclerosis patients J Exp Med 2005, 201:805-816. 2212822 15738052 10.1084/jem.20041679
54. Thiel A Alexander T Schmidt CA Przybylski GK Kimmig S Kohler S Radtke H GromnicaIhle E Massenkeil G Radbruch A Arnold R Hiepe F Direct assessment of thymic reactivation after autologous stem cell transplantation Acta Haematol 2008, 119:22-27. 10.1159/000117824 18292651
55. Peggs KS Reconstitution of adaptive and innate immunity following allogeneic hematopoietic stem cell transplantation in humans Cytotherapy 2006, 8:427-436. 10.1080/14653240600851938 17050247
56. Hakim FT Cepeda R Kaimei S Mackall CL McAtee N Zujewski J Cowan K Gress RE Constraints on CD4 recovery post-chemotherapy in adults: Thymic insufficiency and apoptotic decline of expanded peripheral CD4 cells Blood 1997, 90:3789-3798. 9345067
57. +T-cell regenerative pathways result in prolonged T-cell subset imbalance after intensive chemotherapy Blood 1997, 89:3700-3707. 9160675
58. Tayebi H Kuttler F Saas P Lienard A Petracca B Lapierre V Ferrand C Fest T Cahn J Blaise D Kuentz M Hervé P Tiberghien P Robinet E Effect of granulocyte colony-stimulating factor mobilization on phenotypical and functional properties of immune cells Exp Hematol 2001, 29:458-470. 10.1016/S0301-472X(01)00613-0 11301186
59. Talmadge JE Reed E Ino K Kessinger A Kuszynski C Heimann D Varney M Jackson J Vose JM Bierman PJ Rapid immunologic reconstitution following transplantation with mobilized peripheral blood stem cells as compared to bone marrow Bone Marrow Transplant 1997, 19:161-172. 10.1038/ sj.bmt.1700626 9116614
60. Storek J Dawson MA Storer B Stevens-Ayers T Maloney DG Marr KA Witherspoon RP Bensinger W Flowers ME Martin P Storb R Appelbaum FR Boeckh M Immune reconstitution after allogeneic marrow transplantation compared with blood stem cell transplantation Blood 2001, 97:3380-3389. 10.1182/blood.V97.11.3380 11369627
61. Chen X Vodanovic-Jankovic S Johnson B Keller M Komorowski R Drobyski WR Absence of regulatory T-cell control of TH1 and TH17 cells is responsible for the autoimmune-mediated pathology in chronic graft-versus-host disease Blood 2007, 110:3804-3813. 10.1182/ blood-2007-05-091074 17693581
62. Ruggeri L Capanni M Urbani E Perruccio K Shlomchik WD Tosti A Posati S Rogaia D Frassoni F Aversa F Martelli MF Velardi A Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants Science 2002, 295:2097-2100. 10.1126/science.1068440 11896281
63. Kamath AT Henri S Battye F Tough DF Shortman K Developmental kinetics and lifespan of dendritic cells in mouse lymphoid organs Blood 2002, 100:1734-1741. 12176895
64. Flierman R Westerhuis G Hameetman M van Duivenvoorde LM van Hall T van Laar JM Fibbe WE Toes RE Targeting host B-cell immune responses by persistent donor NK-cell alloreactivity following nonmyeloablative allogeneic stem cell transplantation Blood 2007, 109:5524-5525. 10.1182/ blood-2006-12-065144 17554069
65. Tyndall A Gratwohl A Blood and marrow stem cell transplants in autoimmune disease. A consensus report written on behalf of the European League Against Rheumatism (EULAR) and the European Group for Blood and Marrow Transplantation (EBMT) Br J Rheum 1997, 36:390-392. 9133976 10.1093/rheumatology/36.3.390